TipRanks
Go Ultimate55% OFF

Compare Vitasora Health (VHLUF) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
VHLUFVitasora Health$0.06$19.81M-2.07-3.33%―Unlock the VHLUF analyst price target with TipRanks PremiumVHLUFUnlock the VHLUF top-analyst price target with TipRanks Premium
AU:ONEOneview Healthcare Chess Depository Interests repr 1AUD 0.13AUD 109.10M-6.40-31.58%Moderate BuyUnlock the AU:ONE analyst price target with TipRanks PremiumVHLUF vs AU:ONEUnlock the AU:ONE top-analyst price target with TipRanks Premium
AU:M7TMach7 TechnologiesAUD 0.26AUD 61.10M-6.84-11.86%Moderate BuyUnlock the AU:M7T analyst price target with TipRanks PremiumVHLUF vs AU:M7TUnlock the AU:M7T top-analyst price target with TipRanks Premium
AU:BMTBeamtree Holdings LtdAUD 0.07AUD 21.26M-1.14-64.00%Moderate BuyUnlock the AU:BMT analyst price target with TipRanks PremiumVHLUF vs AU:BMTUnlock the AU:BMT top-analyst price target with TipRanks Premium
AU:ALCAlcidion Group LimitedAUD 0.11AUD 148.48M64.7017.02%Strong BuyUnlock the AU:ALC analyst price target with TipRanks PremiumVHLUF vs AU:ALCUnlock the AU:ALC top-analyst price target with TipRanks Premium
AU:PCKPainChek LtdAUD 0.08AUD 16.32M-1.80-83.04%―Unlock the AU:PCK analyst price target with TipRanks PremiumVHLUF vs AU:PCKUnlock the AU:PCK top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
VHLUFVitasora Health0.060.000.00%
AU:ONEOneview Healthcare Chess Depository Interests repr 10.13-0.06-31.58%
AU:M7TMach7 Technologies0.26-0.04-13.33%
AU:BMTBeamtree Holdings Ltd0.07-0.15-67.27%
AU:ALCAlcidion Group Limited0.110.0222.22%
AU:PCKPainChek Ltd0.08-0.37-82.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts